Oct 12, 2026 06:52AM

Oct 12, 2026 02:24AM

Sep 23, 2026 04:06PM

Aug 11, 2026 04:16PM

Jun 14, 2026 02:01PM

Jun 1, 2026 01:46PM

Jun 1, 2026 06:59AM H.C. Wainwright Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)

May 6, 2026 04:41PM

Apr 27, 2026 05:29AM

Mar 13, 2026 12:40PM

Mar 13, 2026 07:59AM

Mar 13, 2026 07:33AM

Mar 12, 2026 04:14PM

Mar 10, 2026 09:32AM Stifel Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS), Optimistic on lorundrostat

Mar 10, 2026 06:12AM

Dec 19, 2025 07:40AM

Nov 10, 2025 04:20PM

Nov 6, 2025 02:26PM

Sep 8, 2025 07:13AM

Sep 3, 2025 05:33AM

Aug 18, 2025 02:08PM Jefferies Reiterates Hold Rating on Mineralys Therapeutics, Inc. (MLYS)

Aug 12, 2025 04:09PM

Jul 14, 2025 08:20AM

Jun 30, 2025 11:19AM

Jun 18, 2025 06:44AM

Jun 17, 2025 07:00AM

Jun 10, 2025 04:15PM

May 20, 2025 08:01AM Mineralys Therapeutics (MLYS) Announces Late-Breaking Presentation of Phase 3 Launch-HTN Trial at 34th European Meeting on Hypertension and Cardiovascular Protection

May 12, 2025 04:28PM

Apr 23, 2025 05:25PM

Mar 31, 2025 08:18AM

Mar 17, 2025 08:00AM

Mar 11, 2025 10:20PM

Mar 10, 2025 04:03PM

Mar 10, 2025 04:01PM Mineralys Therapeutics (MLYS) Announces Proposed $250M Share Offering

Mar 10, 2025 10:40AM

Mar 10, 2025 07:01AM

Mar 7, 2025 04:01PM

Feb 25, 2025 09:40AM

Feb 12, 2025 07:04AM

Feb 4, 2025 08:06AM

Jan 8, 2025 08:06AM Mineralys Therapeutics (MLYS) Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension

Nov 11, 2024 04:06PM

Aug 14, 2024 05:52AM

Aug 14, 2024 05:23AM

Aug 13, 2024 04:07PM

Jul 10, 2024 06:18AM

Jun 14, 2024 08:01AM

466,315 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All